At the same time, aggressive treatment declined in men with low-risk prostate cancer as might have been expected in an era ...

Increasing numbers of older US men with prostate cancer are undergoing treatments that carry risks of side effects that can ...

The study notes that while "prostate cancer is the most common caner among men in the United States . . . modifiable risk ...

Researchers at City of Hope now understand why taking an investigational white button mushroom supplement shows promise in ...

Men who undergo prostate cancer treatment face a greatly increased risk of life-altering, long-term complications, a new ...

Metastatic castration-resistant prostate cancer (mCRPC) is a severe form of late-stage disease where the tumor can no longer ...

Steves opened up about his cancer battle in a new interview with People magazine. He announced his prostate cancer diagnosis ...

Increasing percentages of some older U.S. men with intermediate-risk and high-risk prostate cancers are undergoing treatments ...

Routt County resident James Onufrak knew his dad was diagnosed with prostate cancer at age 61, so he worked with his own ...

Despite generic headwinds to Xarelto and challenges across different sectors of the conglomerate suggesting “twists and turns ...

Researchers have found an association between baseline circulating tumor cell count and survival in metastatic ...

Prostate cancer treatment guidelines recommend against aggressive therapy for those with a life expectancy of less than 10 years.